1. Home
  2. ENSG vs RDY Comparison

ENSG vs RDY Comparison

Compare ENSG & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Ensign Group Inc.

ENSG

The Ensign Group Inc.

HOLD

Current Price

$147.23

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.39

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENSG
RDY
Founded
1999
1984
Country
United States
India
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
11.6B
IPO Year
2007
2001

Fundamental Metrics

Financial Performance
Metric
ENSG
RDY
Price
$147.23
$13.39
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$202.60
$16.90
AVG Volume (30 Days)
640.3K
1.8M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
0.14%
0.52%
EPS Growth
14.06
N/A
EPS
1.67
N/A
Revenue
$5,057,841,000.00
N/A
Revenue This Year
$17.07
$7.72
Revenue Next Year
$9.49
$3.50
P/E Ratio
$90.81
$18.67
Revenue Growth
18.72
N/A
52 Week Low
$134.80
$12.19
52 Week High
$218.00
$15.97

Technical Indicators

Market Signals
Indicator
ENSG
RDY
Relative Strength Index (RSI) 23.21 50.17
Support Level N/A $12.86
Resistance Level $181.79 $13.95
Average True Range (ATR) 5.97 0.19
MACD -1.48 -0.00
Stochastic Oscillator 20.30 46.41

Price Performance

Historical Comparison
ENSG
RDY

About ENSG The Ensign Group Inc.

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: